279 related articles for article (PubMed ID: 8806634)
1. Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR.
Kendall RL; Wang G; Thomas KA
Biochem Biophys Res Commun; 1996 Sep; 226(2):324-8. PubMed ID: 8806634
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the VEGF binding site on the Flt-1 receptor.
Herley MT; Yu Y; Whitney RG; Sato JD
Biochem Biophys Res Commun; 1999 Sep; 262(3):731-8. PubMed ID: 10471394
[TBL] [Abstract][Full Text] [Related]
3. Differential binding characteristics and cellular inhibition by soluble VEGF receptors 1 and 2.
Roeckl W; Hecht D; Sztajer H; Waltenberger J; Yayon A; Weich HA
Exp Cell Res; 1998 May; 241(1):161-70. PubMed ID: 9633524
[TBL] [Abstract][Full Text] [Related]
4. Soluble Flt-1 (soluble VEGFR-1), a potent natural antiangiogenic molecule in mammals, is phylogenetically conserved in avians.
Yamaguchi S; Iwata K; Shibuya M
Biochem Biophys Res Commun; 2002 Mar; 291(3):554-9. PubMed ID: 11855824
[TBL] [Abstract][Full Text] [Related]
5. Interactions of FLT-1 and KDR with phospholipase C gamma: identification of the phosphotyrosine binding sites.
Cunningham SA; Arrate MP; Brock TA; Waxham MN
Biochem Biophys Res Commun; 1997 Nov; 240(3):635-9. PubMed ID: 9398617
[TBL] [Abstract][Full Text] [Related]
6. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
Lu D; Jimenez X; Zhang H; Wu Y; Bohlen P; Witte L; Zhu Z
Cancer Res; 2001 Oct; 61(19):7002-8. PubMed ID: 11585724
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneous vascular endothelial growth factor (VEGF) isoform mRNA and receptor mRNA expression in human glomeruli, and the identification of VEGF148 mRNA, a novel truncated splice variant.
Whittle C; Gillespie K; Harrison R; Mathieson PW; Harper SJ
Clin Sci (Lond); 1999 Sep; 97(3):303-12. PubMed ID: 10464055
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells.
Barleon B; Siemeister G; Martiny-Baron G; Weindel K; Herzog C; Marmé D
Cancer Res; 1997 Dec; 57(23):5421-5. PubMed ID: 9393770
[TBL] [Abstract][Full Text] [Related]
9. The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade.
Davis-Smyth T; Chen H; Park J; Presta LG; Ferrara N
EMBO J; 1996 Sep; 15(18):4919-27. PubMed ID: 8890165
[TBL] [Abstract][Full Text] [Related]
10. Possible involvement of VEGF-FLT tyrosine kinase receptor system in normal and tumor angiogenesis.
Shibuya M; Seetharam L; Ishii Y; Sawano A; Gotoh N; Matsushime H; Yamaguchi S
Princess Takamatsu Symp; 1994; 24():162-70. PubMed ID: 8983073
[TBL] [Abstract][Full Text] [Related]
11. The coronary endothelium: a target for vascular endothelial growth factor. Human coronary artery endothelial cells express functional receptors for vascular endothelial growth factor in vitro and in vivo.
Kranz A; Mayr U; Frank H; Waltenberger J
Lab Invest; 1999 Aug; 79(8):985-91. PubMed ID: 10462036
[TBL] [Abstract][Full Text] [Related]
12. Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor.
Pan B; Li B; Russell SJ; Tom JY; Cochran AG; Fairbrother WJ
J Mol Biol; 2002 Feb; 316(3):769-87. PubMed ID: 11866530
[TBL] [Abstract][Full Text] [Related]
13. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases.
Meyer M; Clauss M; Lepple-Wienhues A; Waltenberger J; Augustin HG; Ziche M; Lanz C; Büttner M; Rziha HJ; Dehio C
EMBO J; 1999 Jan; 18(2):363-74. PubMed ID: 9889193
[TBL] [Abstract][Full Text] [Related]
14. The fourth immunoglobulin-like loop in the extracellular domain of FLT-1, a VEGF receptor, includes a major heparin-binding site.
Park M; Lee ST
Biochem Biophys Res Commun; 1999 Nov; 264(3):730-4. PubMed ID: 10544000
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of hepatic stellate cell contraction during activation in vitro by vascular endothelial growth factor in association with upregulation of FLT tyrosine kinase receptor family, FLT-1.
Mashiba S; Mochida S; Ishikawa K; Inao M; Matsui A; Ohno A; Ikeda H; Nagoshi S; Shibuya M; Fujiwara K
Biochem Biophys Res Commun; 1999 May; 258(3):674-8. PubMed ID: 10329444
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of vascular endothelial growth factor and its receptor fms-like-tyrosine kinase is mediated by nitric oxide in rat renal mesangial cells.
Frank S; Stallmeyer B; Kämpfer H; Schaffner C; Pfeilschifter J
Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):367-74. PubMed ID: 10024512
[TBL] [Abstract][Full Text] [Related]
17. Uterine smooth muscle cells express functional receptors (flt-1 and KDR) for vascular permeability factor/vascular endothelial growth factor.
Brown LF; Detmar M; Tognazzi K; Abu-Jawdeh G; Iruela-Arispe ML
Lab Invest; 1997 Feb; 76(2):245-55. PubMed ID: 9042161
[TBL] [Abstract][Full Text] [Related]
18. Role of VEGF receptor-1 (Flt-1) in mediating calcium-dependent nitric oxide release and limiting DNA synthesis in human trophoblast cells.
Ahmed A; Dunk C; Kniss D; Wilkes M
Lab Invest; 1997 Jun; 76(6):779-91. PubMed ID: 9194854
[TBL] [Abstract][Full Text] [Related]
19. Gene transfer of a soluble receptor of VEGF inhibits the growth of experimental eyelid malignant melanoma.
Shiose S; Sakamoto T; Yoshikawa H; Hata Y; Kawano Y; Ishibashi T; Inomata H; Takayama K; Ueno H
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2395-403. PubMed ID: 10937546
[TBL] [Abstract][Full Text] [Related]
20. Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis.
Valter MM; Hügel A; Huang HJ; Cavenee WK; Wiestler OD; Pietsch T; Wernert N
Cancer Res; 1999 Nov; 59(21):5608-14. PubMed ID: 10554042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
